• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An update on iron physiology.铁生理学的最新进展。
World J Gastroenterol. 2009 Oct 7;15(37):4617-26. doi: 10.3748/wjg.15.4617.
2
Hepcidin and iron homeostasis.铁调素与铁稳态。
Biochim Biophys Acta. 2012 Sep;1823(9):1434-43. doi: 10.1016/j.bbamcr.2012.01.014. Epub 2012 Jan 26.
3
Disorders of iron metabolism. Part II: iron deficiency and iron overload.铁代谢紊乱。第二部分:缺铁和铁过载。
J Clin Pathol. 2011 Apr;64(4):287-96. doi: 10.1136/jcp.2010.086991. Epub 2010 Dec 20.
4
Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.铁平衡与铁调素在慢性肾脏病中的作用
Semin Nephrol. 2016 Mar;36(2):87-93. doi: 10.1016/j.semnephrol.2016.02.001.
5
The molecular basis of iron overload disorders and iron-linked anemias.铁过载疾病和铁相关性贫血的分子基础。
Int J Hematol. 2011 Jan;93(1):14-20. doi: 10.1007/s12185-010-0760-0. Epub 2011 Jan 7.
6
Iron sequestration and anemia of inflammation.铁螯合与炎症性贫血
Semin Hematol. 2009 Oct;46(4):387-93. doi: 10.1053/j.seminhematol.2009.06.001.
7
[The role of hepcidin in iron metabolism in inflammatory bowel diseases].[铁调素在炎症性肠病铁代谢中的作用]
Postepy Hig Med Dosw (Online). 2014;68:936-43. doi: 10.5604/17322693.1111365.
8
Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis.铁代谢紊乱。第 1 部分:铁动态平衡的分子基础。
J Clin Pathol. 2011 Apr;64(4):281-6. doi: 10.1136/jcp.2010.079046. Epub 2010 Dec 20.
9
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.慢性病贫血和缺铁性贫血中铁稳态的调节:诊断和治疗意义
Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17.
10
Iron and hepcidin: a story of recycling and balance.铁与铁调素:一个关于循环利用与平衡的故事。
Hematology Am Soc Hematol Educ Program. 2013;2013:1-8. doi: 10.1182/asheducation-2013.1.1.

引用本文的文献

1
Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap.挑战基于生理学的铁-碳水化合物纳米药物静脉给药药代动力学模型的传统ADME假设:金纳米颗粒模型作为路线图的潜在效用
Clin Pharmacokinet. 2025 Aug 15. doi: 10.1007/s40262-025-01561-w.
2
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.调节衰老过程中的铁死亡:天然产物的治疗潜力。
J Aging Res. 2025 Jul 3;2025:8832992. doi: 10.1155/jare/8832992. eCollection 2025.
3
Inflammatory bowel disease and hereditary hemochromatosis: A case series.炎症性肠病与遗传性血色素沉着症:病例系列
JPGN Rep. 2025 Feb 23;6(2):126-131. doi: 10.1002/jpr3.12167. eCollection 2025 May.
4
Effects of Dietary Iron Levels on the Production Performance, Nutrient Digestibility, Blood Biochemistry, and Meat and Fur Quality of Growing Rex Rabbits.日粮铁水平对生长獭兔生产性能、养分消化率、血液生化指标及肉和皮毛品质的影响
Animals (Basel). 2025 Jan 19;15(2):274. doi: 10.3390/ani15020274.
5
The Association Between Periodontal Inflamed Surface Area (PISA), Inflammatory Biomarkers, and Mitochondrial DNA Copy Number.牙周炎症表面积(PISA)、炎症生物标志物与线粒体DNA拷贝数之间的关联
J Clin Med. 2024 Dec 25;14(1):24. doi: 10.3390/jcm14010024.
6
Effect of iron status on myocardial infarction: A two-sample Mendelian randomization study.铁状态对心肌梗死的影响:一项两样本孟德尔随机化研究。
Heliyon. 2024 Nov 19;10(24):e40516. doi: 10.1016/j.heliyon.2024.e40516. eCollection 2024 Dec 30.
7
Genetic insights into the effect of trace elements on cardiovascular diseases: multi-omics Mendelian randomization combined with linkage disequilibrium score regression analysis.微量元素对心血管疾病影响的遗传学见解:多组学孟德尔随机化结合连锁不平衡评分回归分析
Front Immunol. 2024 Dec 3;15:1459465. doi: 10.3389/fimmu.2024.1459465. eCollection 2024.
8
Efficacy and safety of preoperative intravenous iron versus standard care in colorectal cancer patients with iron deficiency anemia: a systematic review and meta-analysis.术前静脉注射铁剂与标准治疗对缺铁性贫血结直肠癌患者的疗效及安全性:一项系统评价与荟萃分析
Ann Med Surg (Lond). 2024 Nov 11;86(12):7105-7119. doi: 10.1097/MS9.0000000000002727. eCollection 2024 Dec.
9
Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer.胃癌患者胃切除术后营养不良及营养支持的影响
Ann Gastroenterol Surg. 2024 Mar 16;8(4):534-552. doi: 10.1002/ags3.12788. eCollection 2024 Jul.
10
Enteral Nutrition in Operated-On Gastric Cancer Patients: An Update.术后胃癌患者的肠内营养:最新进展。
Nutrients. 2024 May 27;16(11):1639. doi: 10.3390/nu16111639.

本文引用的文献

1
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.慢性病贫血和缺铁性贫血中铁稳态的调节:诊断和治疗意义
Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17.
2
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.由于铁摄取或血红素合成缺陷导致的遗传性小细胞贫血的分子基础。
Haematologica. 2009 Mar;94(3):395-408. doi: 10.3324/haematol.13619. Epub 2009 Jan 30.
3
Forging a field: the golden age of iron biology.开创一个领域:铁生物学的黄金时代。
Blood. 2008 Jul 15;112(2):219-30. doi: 10.1182/blood-2007-12-077388.
4
Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats.二价金属离子转运体1表达降低和铁转运蛋白1表达增加是促红细胞生成素降低大鼠巨噬细胞中铁潴留的机制。
J Cell Biochem. 2008 May 15;104(2):629-41. doi: 10.1002/jcb.21654.
5
Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion.静脉铁剂治疗作为异体输血替代/辅助治疗的疗效与安全性。
Vox Sang. 2008 Apr;94(3):172-183. doi: 10.1111/j.1423-0410.2007.01014.x. Epub 2007 Dec 7.
6
The role of transporters in cellular heme and porphyrin homeostasis.转运蛋白在细胞血红素和卟啉稳态中的作用。
Pharmacol Ther. 2007 Jun;114(3):345-58. doi: 10.1016/j.pharmthera.2007.02.001. Epub 2007 Feb 21.
7
Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.网织红细胞血红蛋白当量(Ret He)与缺铁状态评估
Clin Lab Haematol. 2006 Oct;28(5):303-8. doi: 10.1111/j.1365-2257.2006.00812.x.
8
Normal iron metabolism and the pathophysiology of iron overload disorders.正常铁代谢与铁过载疾病的病理生理学
Clin Biochem Rev. 2006 Feb;27(1):5-16.
9
Hepcidin and iron-loading anemias.铁调素与铁过载性贫血
Haematologica. 2006 Jun;91(6):727-32.
10
Lineage-specific hematopoietic growth factors.谱系特异性造血生长因子。
N Engl J Med. 2006 May 11;354(19):2034-45. doi: 10.1056/NEJMra052706.

铁生理学的最新进展。

An update on iron physiology.

作者信息

Muñoz Manuel, Villar Isabel, García-Erce José Antonio

机构信息

Transfusion Medicine, School of Medicine, University of Málaga, Málaga 29071, Spain.

出版信息

World J Gastroenterol. 2009 Oct 7;15(37):4617-26. doi: 10.3748/wjg.15.4617.

DOI:10.3748/wjg.15.4617
PMID:19787824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2754509/
Abstract

Iron is an essential micronutrient, as it is required for adequate erythropoietic function, oxidative metabolism and cellular immune responses. Although the absorption of dietary iron (1-2 mg/d) is regulated tightly, it is just balanced with losses. Therefore, internal turnover of iron is essential to meet the requirements for erythropoiesis (20-30 mg/d). Increased iron requirements, limited external supply, and increased blood loss may lead to iron deficiency (ID) and iron-deficiency anemia. Hepcidin, which is made primarily in hepatocytes in response to liver iron levels, inflammation, hypoxia and anemia, is the main iron regulatory hormone. Once secreted into the circulation, hepcidin binds ferroportin on enterocytes and macrophages, which triggers its internalization and lysosomal degradation. Thus, in chronic inflammation, the excess of hepcidin decreases iron absorption and prevents iron recycling, which results in hypoferremia and iron-restricted erythropoiesis, despite normal iron stores (functional ID), and anemia of chronic disease (ACD), which can evolve to ACD plus true ID (ACD + ID). In contrast, low hepcidin expression may lead to iron overload, and vice versa. Laboratory tests provide evidence of iron depletion in the body, or reflect iron-deficient red cell production. The appropriate combination of these laboratory tests help to establish a correct diagnosis of ID status and anemia.

摘要

铁是一种必需的微量营养素,因为充足的红细胞生成功能、氧化代谢和细胞免疫反应都需要铁。尽管膳食铁(1-2毫克/天)的吸收受到严格调节,但它仅与铁的流失保持平衡。因此,铁的内部周转对于满足红细胞生成的需求(20-30毫克/天)至关重要。铁需求增加、外部供应有限以及失血增加可能导致缺铁(ID)和缺铁性贫血。铁调素主要由肝细胞根据肝脏铁水平、炎症、缺氧和贫血情况产生,是主要的铁调节激素。一旦分泌到循环系统中,铁调素就会与肠上皮细胞和巨噬细胞上的铁转运蛋白结合,从而引发其内化和溶酶体降解。因此,在慢性炎症中,铁调素过量会减少铁的吸收并阻止铁的再循环,尽管铁储备正常(功能性缺铁),但仍会导致低铁血症和铁限制的红细胞生成,以及慢性病贫血(ACD),后者可能会发展为ACD加真正的缺铁(ACD + ID)。相反,铁调素表达低可能导致铁过载,反之亦然。实验室检查可提供体内铁缺乏的证据,或反映缺铁性红细胞生成情况。这些实验室检查的适当组合有助于对缺铁状态和贫血做出正确诊断。